Injectable hydrogel 'could repair effects of a heart attack'

24 February 2012

A new injectable hydrogel could enhance how a human being's body recovers from severe heart problems.

Researchers at the University of California in San Diego have created the material, which has the capability to repair tissue damage following a heart attack.

Deemed to be both safe and effective in its delivery, the hydrogel looks set to be the first established treatment which exclusively tends to damaged cardiac tissue.

Karen Christman and her colleagues at the California-based institute are the brains behind the development, with the researchers creating the hydrogel using cardiac connective tissue which is taken from heart muscle cells.

Commenting on the potential breakthrough, Ms Christman said: "It helps to promote a positive remodelling-type response, not a pro-inflammatory one in the damaged heart."

University of Nottingham researchers have also looked into new treatments for heart problems, with a team at the institution developing a mathematical model of the vital human organ which displays its calcium activity process.

Posted by Philip Briggs


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.
 

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cardiac

© Spire Healthcare Group plc (2016)